180 Life Sciences Corporate Media Kit

20 SCA Pipeline* Development of lead SCA Phase1 Phase 2a/b Chronic pain in RA Results SCA pipeline Phase 2a/b in early arthritis (tbc) Therapeutic development of SCA 2 Preclinical development of SCA2 Indication tbc 2020 2021 2022 2023 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 *Based on current proposals. No regulatory approvals sought from appropriate authorities at this time. Execution and analysis Planning and regulatory 180 Life Sciences Corp. www.180lifesciences.com Q4 2020